Report cover image

Global Endorphins Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 180 Pages
SKU # APRC20356211

Description

Summary

According to APO Research, The global Endorphins market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Endorphins include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endorphins, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Endorphins, also provides the sales of main regions and countries. Of the upcoming market potential for Endorphins, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endorphins sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Endorphins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Endorphins sales, projected growth trends, production technology, application and end-user industry.

Endorphins Segment by Company

Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Egalet Corp.
Endo International Plc
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Endorphins Segment by Type

Sigma-Endorphins
Gamma-Endorphins
Beta-Endorphins
Alpha-Endorphins
Endorphins Segment by Application

Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Endorphins Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endorphins market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

180 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Endorphins Market Size, 2020 VS 2024 VS 2031
1.3 Global Endorphins Market Size Estimates and Forecasts (2020-2031)
1.4 Global Endorphins Sales Estimates and Forecasts (2020-2031)
1.5 Global Endorphins Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Endorphins Market Dynamics
2.1 Endorphins Industry Trends
2.2 Endorphins Industry Drivers
2.3 Endorphins Industry Opportunities and Challenges
2.4 Endorphins Industry Restraints
3 Endorphins Market by Manufacturers
3.1 Global Endorphins Revenue by Manufacturers (2020-2025)
3.2 Global Endorphins Sales by Manufacturers (2020-2025)
3.3 Global Endorphins Average Sales Price by Manufacturers (2020-2025)
3.4 Global Endorphins Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Endorphins Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Endorphins Manufacturers, Product Type & Application
3.7 Global Endorphins Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Endorphins Market CR5 and HHI
3.8.2 Global Top 5 and 10 Endorphins Players Market Share by Revenue in 2024
3.8.3 2024 Endorphins Tier 1, Tier 2, and Tier 3
4 Endorphins Market by Type
4.1 Endorphins Type Introduction
4.1.1 Sigma-Endorphins
4.1.2 Gamma-Endorphins
4.1.3 Beta-Endorphins
4.1.4 Alpha-Endorphins
4.2 Global Endorphins Sales by Type
4.2.1 Global Endorphins Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Endorphins Sales by Type (2020-2031)
4.2.3 Global Endorphins Sales Market Share by Type (2020-2031)
4.3 Global Endorphins Revenue by Type
4.3.1 Global Endorphins Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Endorphins Revenue by Type (2020-2031)
4.3.3 Global Endorphins Revenue Market Share by Type (2020-2031)
5 Endorphins Market by Application
5.1 Endorphins Application Introduction
5.1.1 Institutional Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.2 Global Endorphins Sales by Application
5.2.1 Global Endorphins Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Endorphins Sales by Application (2020-2031)
5.2.3 Global Endorphins Sales Market Share by Application (2020-2031)
5.3 Global Endorphins Revenue by Application
5.3.1 Global Endorphins Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Endorphins Revenue by Application (2020-2031)
5.3.3 Global Endorphins Revenue Market Share by Application (2020-2031)
6 Global Endorphins Sales by Region
6.1 Global Endorphins Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Endorphins Sales by Region (2020-2031)
6.2.1 Global Endorphins Sales by Region (2020-2025)
6.2.2 Global Endorphins Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Endorphins Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Endorphins Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Endorphins Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Endorphins Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Endorphins Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Endorphins Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Endorphins Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Endorphins Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Endorphins Revenue by Region
7.1 Global Endorphins Revenue by Region
7.1.1 Global Endorphins Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Endorphins Revenue by Region (2020-2025)
7.1.3 Global Endorphins Revenue by Region (2026-2031)
7.1.4 Global Endorphins Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Endorphins Revenue (2020-2031)
7.2.2 North America Endorphins Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Endorphins Revenue (2020-2031)
7.3.2 Europe Endorphins Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Endorphins Revenue (2020-2031)
7.4.2 Asia-Pacific Endorphins Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Endorphins Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Endorphins Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Assertio Therapeutics Inc.
8.1.1 Assertio Therapeutics Inc. Comapny Information
8.1.2 Assertio Therapeutics Inc. Business Overview
8.1.3 Assertio Therapeutics Inc. Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
8.1.5 Assertio Therapeutics Inc. Recent Developments
8.2 Cipher Pharmaceuticals Inc.
8.2.1 Cipher Pharmaceuticals Inc. Comapny Information
8.2.2 Cipher Pharmaceuticals Inc. Business Overview
8.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
8.2.5 Cipher Pharmaceuticals Inc. Recent Developments
8.3 Egalet Corp.
8.3.1 Egalet Corp. Comapny Information
8.3.2 Egalet Corp. Business Overview
8.3.3 Egalet Corp. Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Egalet Corp. Endorphins Product Portfolio
8.3.5 Egalet Corp. Recent Developments
8.4 Endo International Plc
8.4.1 Endo International Plc Comapny Information
8.4.2 Endo International Plc Business Overview
8.4.3 Endo International Plc Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Endo International Plc Endorphins Product Portfolio
8.4.5 Endo International Plc Recent Developments
8.5 Lannett Co. Inc.
8.5.1 Lannett Co. Inc. Comapny Information
8.5.2 Lannett Co. Inc. Business Overview
8.5.3 Lannett Co. Inc. Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Lannett Co. Inc. Endorphins Product Portfolio
8.5.5 Lannett Co. Inc. Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Endorphins Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Johnson & Johnson
8.7.1 Johnson & Johnson Comapny Information
8.7.2 Johnson & Johnson Business Overview
8.7.3 Johnson & Johnson Endorphins Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Johnson & Johnson Endorphins Product Portfolio
8.7.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Endorphins Value Chain Analysis
9.1.1 Endorphins Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Endorphins Production Mode & Process
9.2 Endorphins Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Endorphins Distributors
9.2.3 Endorphins Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.